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ABSTRACT 
Therapeutic drug monitoring (TDM) is highly required for drugs possessing narrow therapeutic index as a slight variation in the therapeutic range could result 
in no or low clinical efficiency or causes significant side effects or high risk of toxicity. In recent days, reverse iontophoresis technique has been attempted for 
the non invasive drug monitoring. Typically, it applies a low electric current through a pair of skin electrodes to promote the transport of both charged and 
neutral molecules. Transdermal iontophoretic extraction of propranolol was carried out and the study involves effect of different solvents having their different 
pH  values  on  the  iontophoretic  extraction,  effect  of  different  voltages  on  the  iontophoretic  extraction,  effect  of  different  permeation  enhancers  on  the 
permeability of propranolol hydrochloride and the effect of stratum corneum removal on the permeability of propranolol. Iontophoretic diffusion was carried 
out in vitro using full thickness rat skin. The efficient quantity of propranolol was collected at cathode by electromigration. The correlation between the 
extracted  fluxes  of  propranolol  and  its  subdermal  concentration  was  found  to  be  adequate.  The  values  of  extraction  fluxes  didn’t  attain  a  steady  state 
throughout  the  experiment. The  decrease in the  solvent  pH  doesn’t affect the transdermal  extraction of propranolol. The  decrease in the  voltage  causes 
diminishes in the iontophoretic fluxes. The application of permeation enhancers especially propylene glycol causes significantly increase in the iontophoretic 
fluxes of propranolol. Thus it is concluded that propranolol hydrochloride can be quantitatively extracted by reverse iontophoresis in varying conditions of 
subdermal concentration 
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INTRODUCTION 
Therapeutic drug monitoring (TDM) was introduced in the 
early  1970s  with  the  objectives  of  improving  the  patient 
safety,  individualize  the  dosage  regimen  and  surmount  the 
systemic toxicity. In general, clinical tests are performed very 
frequently to determine the drug concentration in the body 
during the therapy. Essentially, TDM is highly required for 
drugs  possessing  narrow  therapeutic  index  as  a  slight 
variation in the therapeutic range could result in no or low 
clinical efficiency or causes significant side effects or high 
risk  of  toxicity
1.  However,  the  existing  methods  for  drug 
collection such as blood sampling from vein (venipuncture) 
and finger stick method is highly invasive and possess low 
patient compliance especially when the sampling frequency is 
much  high  .  Recently,  research  has  been  focused  on  non-
invasive methods to monitor the drug plasma concentration. 
In  this  contest,  skin  provides  a  unique  gateway  for 
noninvasive transdermal drug monitoring. The application of 
electric current across the skin could be used to extract the 
endogenous molecules within or beneath the skin
2. In recent 
days, reverse iontophoresis technique has been attempted for 
the non invasive drug monitoring. Typically, it applies a low 
electric current through a pair of skin electrodes to promote 
the transport of both charged and neutral molecules
3. Several 
in vitro and in vivo studies have demonstrated the potential of 
reverse iontophoresis to monitor the sub dermal concentration 
of  drugs  and  other  biomolecules
4-10.  One  of  the  most 
successful applications of reverse iontophoresis till today is 
the  noninvasive  glucose  monitoring  employing  the 
Glucowatch. The success of transdermal iontophoresis leads 
the  drug  delivery  scientists  to  focus  on  the  feasibility  of 
iontophoretic extraction (reverse iontophoresis) of molecules 
from the body rather than its forward iontophoretic delivery 
into the body. Further, the symmetry of iontophoresis is such 
that  it  is  possible  to  deliver  molecules  into  the  body  and 
could  also  be  extracted.  In  principle, reverse  iontophoresis 
causes extraction of solute molecules from sub dermal parts 
to skin surface
11. The technical description of this process is a 
non-invasive  method  of  expelling  charged  drug  across  the 
skin by repulsive electromotive force using a small electrical 
charge  applied  to  an  iontophoretic  chambers  containing 
vehicle.  Drug  molecules  (charged/uncharged)  will  be 
transported  from  the  subdermal  region  to  the  electrode  by 
different routes (intracellular, hair follicles and sweat ducts). 
This  technique  can have  important applications in  medical 
diagnostics  as  it  can  allow  non-invasive  sampling  of 
endogenous molecules. In medical diagnostics as it can allow 
non-invasive sampling of endogenous molecules. In reverse 
iontophoresis, the negative charge of the skin at buffered pH 
causes it to be perm selective to cations causing solvent flow 
towards  the  cathode
12.  This  flow  is  the  dominant  force 
allowing movement of neutral molecules, including glucose, 
across  the  skin.  The  redox  reactions  take  place  at  site  of 
electrodes  causes  charge  imbalance  at  both  cathodic  and 
anodic solutions as a result ion migrate to skin to maintain 
electro  neutrality
11.  However,  ions  possessing  specific 
charges  could  be  easily  extracted  by  electro-repulsion
13. 
Moreover, it is required that the concentration of compounds 
extracted from the body is directly related to its sub dermal 
concentration
14.    The  basic  principle  involved  here  is  the 
subdermal  concentration  of  the  analyte  of  interest  can  be 
predicted solely from ratio of extracted fluxes of the analyte 
and internal standard. This has been demonstrated in various 
studies using different analytes including amikacin, valproic 
acid,  lactate,  phenytoin  and  lithium
15-20.  However,  the 
challenges  still  remain  with  neutral  molecules  such  as 
glucose. Here the analyte which has to be investigated is the 
propranolol hydrochloride. Propranolol is a beta blocker & 
beta-blockers  compete  with  endogenous  and/or  exogenous 
beta-adrenergic  agonists.  Propranolol  does  not  possess 
intrinsic  sympathomimetic  activity  and  is  not  a 
cardioselective.  It  performs  the  function  of  membrane 
stabilization  and  is  highly  lipid  soluble.  At  toxic 
concentrations,  propranolol  has  a  prominent  negative Goel Ankit et al. IRJP 2012, 3 (4) 
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chronotropic and inotropic effect and offers the same effect 
like quinidine on heart. The main target organ of propranolol 
is  the  cardiovascular  system.  Propranolol  reduces 
intraventricular  conduction,  sinus  rate,  cardiac  contractility 
and  atrio-ventricular  conduction.  Due  to  its  high 
liposolubility it leads to central nervous system toxicity and 
may cause coma and convulsions
21. The primary objective of 
the current study is to develop a noninvasive method for the 
therapeutic  drug  monitoring  of  Propranolol  Hydrochloride. 
So to conduct the study, the effect of drug concentration on 
reverse  iontophoresis  was  studied  using rat  skin  (in  vitro). 
The effect of change in pH of subdermal solution and voltage 
on  the  extraction  was  also  studied.  The  application  of 
permeation  enhancers  and  stratum  corneum  removal  effect 
was also included under the study.  
MATERIALS AND METHODS 
Materials  
Disodium  hydrogen  phosphates,  Potassium  dihydrogen 
phosphate,  Propylene  glycol,  Tween  80,  Sodium  lauryl 
sulphate  (SLS),  Sodium  hydroxide  were  obtained  from 
Qualikems  Fine  Chem.  Pvt.  Ltd.  Vadodara.  All  these 
chemicals and other chemicals were of analytical grade and 
obtained  from  institutional  chemical  store.  Propranolol 
hydrochloride  was  purchased  from  Micro  labs  Pvt  Ltd 
(Baddi). Deionized water (resistivity > 18MW/cm) was used 
in preparation of all the solutions. Skin of full thickness was 
excised  from  the  rat  obtained  from  the  animal  house, 
wrapped  in  parafilm  and  stored  under  0
0  c  in  refrigerator. 
There is not considerable difference between the permeability 
of new tissue and the stored tissue .The entire animal used in 
the  experiment  was  according  to  the  guidelines  of  animal 
ethical  committee  and  the  conditions  approved  by 
Institutional Ethical Committee (IEC). 
Iontophoretic Experiments 
Reverse iontophoresis experiments involves different series 
of experiments concerning effect of different conditions like 
change  in  solvent  pH,  different  voltage,  permeation 
enhancers and stratum corneum removal (tape stripping). The 
main  idea  behind  this  was  to  optimize  the  propranolol 
extraction  in  various  possible  conditions.  Reverse 
iontophoresis  experiments  were  conducted  using  vertical 
diffusion cell having electrode chambers on upper and lower 
side  separated  by  single  piece  of  rat  skin  placed  between 
them.  In  the  first  series  of  experiment,  propranolol 
iontophoretic  extraction  from  the  subdermal  region  of  the 
diffusion cell was calculated using different solvents having 
their  different  pH.  The  cathodal  compartment  (upper)  was 
filled  with  2  ml  of  each  one  of  Phosphate  buffer  pH  5.0, 
Phosphate buffer pH 6.5 and Phosphate buffer saline pH7.4. 
The  anodal  compartment  (lower)  was  filled  with  5ml  of 
different  concentrations  of  propranolol  hydrochloride  (50, 
100, 1000 µg/ml) prepared in each one of above solvents. A 
control  was  also  carried  out  without  using  power  supply. 
Iontophoretic  extraction  was  carried  out  by  applying  a 
constant voltage of 6V for 6 h from a power source (Amco, 
Ambala) through silver-silver chloride electrodes which was 
inserted into anodal and cathodal chambers. The solutions in 
the compartments were magnetically stirred right through the 
experiment. At the sampling time, power supply was stopped 
and overall contents of the cathodal chambers were taken out 
for measurement and replaced with fresh solvent.  
In the second experiment, the effect of different voltages on 
the  iontophoretic  extraction  of  propranolol  was  studied.  In 
this  experiment  same  vertical  diffusion  cell  was  used  and 
both the compartments were separated by the full thickness 
rat  skin  placed  between  them.  The  cathodal  and  anodal 
solution consists of phosphate buffer saline having pH 7.4.  
In this experiment different voltages were applied (6V, 5V, 
4V),  but  the  sampling  time  and  duration  were  same  as  in 
above experiment.   
In  the  third  experiment,  the  effect  of  different  permeation 
enhancers on the permeability of propranolol hydrochloride 
was studied. In this process , different permeation enhancers 
were  used  like  Tween  80  (2.5%),  Propylene  glycol  (5%), 
Sodium  lauryl  sulphate  (2.5%)  were  used  depending  upon 
their previous reported actions on increasing the permeability 
of  propranolol  hydrochloride
22.  The  experiment  was 
conducted using power supply of 6V and the same diffusion 
cell.  The  cathodal  compartment  was  filled  with  phosphate 
buffer saline having pH 7.4 containing different percentage of 
permeation enhancers, but the anodal compartment was filled 
with phosphate buffer saline pH 7.4. A control experiment 
(without power) was also carried out to study the difference.  
In  the  fourth  and  final  experiment,  the  effect  of  stratum 
corneum  removal  on  the  permeability  of  propranolol 
hydrochloride was examined. In this case, stratum corneum 
(SC) removal was achieved by tape stripping method. Layers 
of SC were removed by applying and removing 25 adhesive 
tapes
23.  The  tissue  became  red  and  shiny,  confirming  the 
removal  of  SC.  The  overall  experimental  conditions  were 
remain  same  as  in  first  experiment  except  solvent  used  in 
both the compartments was phosphate buffer saline having 
pH 7.4. The exposed skin area in each experiment was 0.78 
cm
2 .Ag/AgCl electrodes were prepared as the old fashioned 
method
24. All the experiments were conducted in triplicate to 
minimize  the  error  as  possible  including  passive  diffusion 
studies (without current) as control.  
Analytical method employed 
The detection of amount of propranolol hydrochloride present 
in  different  samples  (extracted  through  the  skin  during 
sampling period) was performed by high performance liquid 
chromatography (HPLC). HPLC system (Cyberlab, LC P100) 
amid U.V detection at 287 nm, using a reverse phase C-18 
analytical  column  (4.6  X  250  mm,  Shiseido,  5  µm)  .The 
mobile  phase  employed  for  detection  was  Acetonitrile  and 
water (adjusted to pH 2.3 with orthophosphoric acid) in the 
ratio of 60:40 v/v, having a flow rate of 1ml/min. The volume 
of injection was 25 µl and the retention time of propranolol 
hydrochloride was 6 .12 min. The LOD was 0.4µg/ml. 
Statistical values 
Propranolol  fluxes  were  calculated  by  dividing  the  total 
amount received in sampling interval by the total collection 
period and is expressed as µg/cm
2/h. The result values were 
uttered as mean ± standard deviation (SD). The comparison 
between  the  statistical  values  of  different  extraction 
conditions  for  each  concentration  of  propranolol  were 
prepared using Bonferroni-Dunn test. 
RESULTS AND DISCUSSION 
Propranolol hydrochloride is a moderate molecule having a 
molecular weight 295 and at physiological pH it acts as  a 
positively  charged  molecule.  The  main  mechanism  of 
transportation is electromigration towards cathode. 
The  first  objective  of  the  work  was  to  demonstrate  the 
possibility  of  iontophoretic  extraction  of  propranolol  and 
effect  of  different  solvent  pH  on  its  extraction.  A  passive 
diffusion study was also carried out and it is found that the 
amount of propranolol extracted in iontophoretic extraction is 
nearly four times greater than passive diffusion. Table 1 and 
fig.  1  shows  the  data  of  extraction  fluxes  of  propranolol 
hydrochloride as a function of their subdermal concentration Goel Ankit et al. IRJP 2012, 3 (4) 
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and  solvent  variation.    Fig  1  clearly  demonstrates  that  the 
values  of  extraction  fluxes  were  greater  in  iontophoretic 
extraction as compared to passive extraction. But the fluxes 
values didn’t achieve the steady state at the time period of 6 
h.    Propranolol  fluxes  increased  as  a  function  of 
concentration in the subdermal .It is found that as there is 
increase in the pH of the subdermal solution there is slightly 
decrease in the flux of propranolol and it may be reported as 
negligible due to other errors that might have occurred during 
the process. When there is application of the current, all ions 
present  in  the  system  shows  competition  in  carrying  of 
charge. It is also expected that only free propranolol can be 
iontophoretically  extracted  from  extracellular  fluids  across 
the skin. There is a difficulty in extraction of protein bound 
propranolol complex as they are large in shape. 
The  results  of  second  experiment  conducted  to  study  the 
effect  of  different  densities  of  voltage  on  transdermal 
extraction are indicated in table 2 and fig 2. The extraction 
fluxes  of  propranolol  are  significantly  altered  by  the 
decreasing the voltage supply to the diffusion cell from 6 V 
to 4 V. The extraction fluxes of propranolol had not achieved 
the steady state throughout the process. It is also studied that 
propranolol  fluxes  are  in  direct  relationship  with  the 
subdermal  concentration  .There  is  linearity  between  the 
extraction  fluxes  and  the  variation  in  the  voltage  supply. 
When  the  power  supply  to  the  diffusion  cell  decreases 
(decrease  in  voltage)  the  momentum  carried  by  the  ions 
becomes  low  and  thus  the  competition  between  ions 
decreased.  
The result of third experiment conducted to study the effect 
of  different  permeation  enhancers  on  the  permeability  of 
propranolol hydrochloride is stated in table 3 and fig 3. For 
this  purpose,  different  permeation  enhancers  were  used 
depending on their previous reported actions on delivery of 
propranolol  hydrochloride
22.  It  is  reported  that  there  is 
significantly  increase  in  the  fluxes  of  propranolol 
hydrochloride in case of permeation enhancers especially in 
case  of  propylene  glycol  (5%).  Permeation  enhancer  deals 
with  the  structure  of  stratum  corneum.  They  modify  the 
structure  of  stratum  corneum,  thus  increasing  the 
permeability. In this case all the permeation enhancers used 
showed  good  result  in  increasing  the  permeability.  The 
extraction fluxes rates increased as a function of permeation 
enhancer  used  and  the  subdermal  concentration.  The 
extraction fluxes didn’t attain a steady state value throughout 
the experiment. 
The  outcome  of  fourth  and  final  experiment  performed  to 
study the effect of stratum corneum removal on transdermal 
extraction is indicated in table 4 and fig 4. It is examined that 
there  is  extensively  increased  in  the  extraction  fluxes  of 
propranolol hydrochloride by the stratum corneum removal. 
Stratum corneum is the main barrier in the drug extraction 
and the drug delivery. There establishes a linearity between 
the  extraction  fluxes  and the  subdermal  concentration.  But 
the extraction fluxes didn’t maintain the steady state. 
Finally,  all  the  above  data  confirms  the  possibility  of  the 
invitro  extraction  of  propranolol  hydrochloride  in  various 
possible  conditions,  the  problem  may  be  arise  in  case  of 
invivo. 
CONCLUSION 
Reverse  iontophoresis  is  a  best  method  to  monitor  the 
concentration  of  propranolol  hydrochloride  and  prompt 
measurement in vitro. By the application of different methods 
we can increase the extraction of drug molecules from the 
body  which  is  useful  in  faster  analysis.  The  various 
applications  of  this  method  along  with  an  alternative  to 
venipuncture make this a useful method. Akin to glucowatch 
which  involves  measurement  and  displaying  the  drug 
concentration,  could  be  equipped  for  propranolol 
hydrochloride  and  this  may  be  useful  to  various  patients 
suffering from its toxicity. 
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Table- 1 (a) 
Solvents used in cathodal and anodal 
chambers 
Propranolol iontophoretic extraction fluxes(µg/cm
2/h) 
  50 µg/ml  100 µg/ml  1000 µg/ml 
Phosphate buffer pH 5.0  4.2 ± 0.3  8.5 ± 1.6  35.9 ± 3.0 
Phosphate buffer pH 6.5  4.5 ±  0.5  8.0 ± 1.4  34.7 ± 2.4 
Phosphate buffer saline pH 7.4  3.8 ± 0.7  6.8  ± 1.1  33.0 ± 2.9 
 
Table- 1 (b) 
Solvents used in cathodal and anodal 
chambers 
Propranolol passive extraction fluxes(µg/cm
2/h) 
  50 µg/ml  100 µg/ml  1000 µg/ml 
Phosphate buffer pH 5.0  1.5 ± 0.08  3.0 ± 1.2  10.8 ± 2.1 
Phosphate buffer pH 6.5  1.3 ± 0.07  2.5 ± 1.4  10.6 ± 1.6 
Phosphate buffer saline pH 7.4  0.9 ± 0.08  2.0 ± 0.9  09.3 ± 1.0 
 
Table- 2 (a) 
Power supplied to diffusion cell  Propranolol iontophoretic extraction fluxes(µg/cm
2/h) 
  50 µg/ml  100 µg/ml  1000 µg/ml 
4 V  1.9 ± 0.4  4.6 ± 1.1  23.9 ± 2.5 
5  V  3.1 ± 0.3  5.5 ± 1.4  28.6 ± 2.1 
6 V  3.8 ± 0.7  6.8 ± 0.8  33.0 ± 1.9 
 
Table- 4 (a) 
Skin used in diffusion cell  Propranolol iontophoretic extraction fluxes(µg/cm
2/h) 
  50 µg/ml  100 µg/ml  1000 µg/ml 
Stratum corneum removed  7.0 ± 1.4  12.5 ± 0.9  54.6 ± 4.1 
 
Table- 3 (a) 
Permeation enhancers used in cathodal 
chambers 
Propranolol iontophoretic extraction fluxes(µg/cm
2/h) 
  50 µg/ml  100 µg/ml  1000 µg/ml 
Propylene glycol 5 %  6.2 ± 1.0  11.2 ± 1.2  47.2 ± 3.1 
Sodium lauryl sulphate 2.5 %  5.6 ± 0.7  10.5 ± 1.7  45.2 ± 2.5 
Tween 80 %  5.8 ± 0.9  11.4 ± 1.6  42.8 ± 2.9 
 
Table- 3 (b) 
Permeation enhancers used in cathodal 
chambers 
Propranolol passive extraction fluxes(µg/cm
2/h) 
  50 µg/ml  100 µg/ml  1000 µg/ml 
Propylene glycol 5 %  1.4 ± 0.06  3.2 ± 0.9  12.5 ± 1.8 
Sodium lauryl sulphate 2.5 %  1.3 ± 0.08  2.9 ± 03  11.9 ± 1.1 
Tween 80 %  1.1 ± 0.09  2.8 ± 0.3  11.2 ± 1.5 
 
Table- 4 (b) 
 
 
 
 
 
 
 
 
Fig. 1. A Iontophoretic extraction fluxes of Propranolol as a function of subdermal concentration and different solvent employed.  
B Passive extraction fluxes of propranolol as a function of subdermal concentration and different solvent employed. 
Skin used in diffusion cell  Propranolol passive extraction fluxes(µg/cm
2/h) 
  50 µg/ml  100 µg/ml  1000 µg/ml 
Stratum corneum removed  1.8 ± 0.08  3.9 ± 0.4  15.0 ± 1.2 Goel Ankit et al. IRJP 2012, 3 (4) 
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Fig. 2. Iontophoretic extraction fluxes of Propranolol as a function of subdermal concentration and different voltages employed. 
 
 
 
 
Fig. 3. A Iontophoretic extraction fluxes of Propranolol as a function of subdermal concentration and different permeation enhancers employed.  
B Passive extraction fluxes of propranolol as a function of subdermal concentration and permeation enhancers employed. 
 
 
 
 
 
Fig. 4. A Iontophoretic extraction fluxes of Propranolol as a function of subdermal concentration and stratum corneum removal of skin.  
B Passive extraction fluxes of propranolol as a function of subdermal concentration and stratum corneum removal of skin. 